| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |